eliemtx.com - ELYM Company Cash Volume

Corporate emblem and logo of eliemtx.com (ELYM)

The business model of Eliem Therapeutics (ELYM) is based on the development of innovative treatments for depression and pain. The cash-on-hand metric on GURU.Markets reflects liquidity dynamics, where the metric level stands at 0.22. This correlates with the efficient operation of R&D laboratories and contract manufacturing. Consequently, Eliem Therapeutics is building a cutting-edge neuropharmacology ecosystem, striving for leadership in the treatment of nervous system disorders.

Eliem Therapeutics Inc. - ELYM Company Cash Volume (period 07/04/2022 - 10/03/2024)

Analytical breakdowns and data insights for company Eliem Therapeutics (ELYM)

- stock value and consensus price forecast:
Fundamental company analysis:ELYM eliemtx.com
Brand item of Eliem

Investors assess the resilience of Eliem Therapeutics (ELYM) through its ability to fund long-term clinical trials for neural pathologies. For pharmaceutical development, a liquidity balance that prevents dependence on external loans is critical. The company's cash history reflects the daily dynamics of available capital, eliminating the risk of purchasing the asset at its peak value. An upward curve confirms effective investment attraction, while stagnation signals a loss of purchasing power. This indicator determines the business's financial strength reserve.

Main competitors

Company Cash Volume BIIB|Company Cash Funds NBIX (Neurocrine Biosciences)|Company Cash Funds Regencell Bioscience Ltd RGC|AXSM (Axsome Therapeutics, Inc.) - Company Total Cash Volume|ACADIA Corp - Company Cash Volume|Company Cash Reserve Xenon Pharmaceuticals|VKTX (Viking Therapeutics Corp) - Company Cash on Hand|Supernus Pharmaceuticals (SUPN) - Company Cash Volume|CPRX (Catalyst Pharma) - Company Cash Volume|DNLI (Denali Therapeutics Inc.) - Company Total Cash Amount|Company Cash Volume HRMY|Biohaven Corp - Company Cash and Cash Equivalents|Company Cash Volume AMLX (amylyx.com)|Company Liquid Assets Trevi Therapeutics, Inc. (TRVI)|Praxis Corp - Company Cash Volume|Company Cash Reserve Anavex|CBLL (CeriBell Inc) - Company Cash on Hand|Company Cash and Cash Equivalents PRTA|Company Cash Funds Alector Inc.|Company Cash Reserve Annexon, Inc. ANNX|Company Cash Funds Omeros Corp (OMER)|NGNE (Neurogene Inc) - Company Cash Balance|Company Cash Funds AC Immune Inc ACIU|Company Cash Position Voyager Corp|Neumora Corp - Company Cash Volume|scilexholding.com (SCLX) - Company Cash on Hand|Tevogen Bio Holdings, Inc. (TVGN) - Company Cash Funds|Alpha Cognition Corp (ACOG) - Company Cash Volume|Company Cash on Hand CGTX|Company Cash and Cash Equivalents IKT (Inhibikase)|Company Cash Volume SAVA|Assertio - Company Cash and Cash Equivalents|Company Cash Volume COYA (Coya Therapeutics)|Company Cash Volume Vistagen Therapeutics VTGN|OVID: Company Cash on Hand|ABOS - Company Cash Volume|CRVO: Company Cash Volume|Company Cash Reserve Alterity Therapeutics Ltd. (ATHE)|Company Cash Funds Clene Inc.|pepgen.com (PEPG) - Company Liquid Assets|Company Cash on Hand JUNS (jupiterneurosciences.com)|Company Cash Funds RLMD (Relmada Corp)|Annovis Bio, Inc. - Company Cash on Hand|Company Cash Position Grace Therapeutics, Inc.|Firefly Neuroscience, Inc - Company Cash Volume|KLTO - Company Cash Volume|NRSN (NeuroSense Therapeutics Ltd.) - Company Cash on Hand|RVPH - Company Liquid Assets|Company Cash Funds MetaVia|Company Cash and Cash Equivalents NRXS (neuraxis.com)|Company Cash Funds Helius Medical Technologies (HSDT)|PASG (Passage Bio) - Company Cash Balance|Company Cash Volume NEUP (Neuphoria Therapeutics)|Company Cash Balance NERV|ATHA - Company Cash Funds|Company Total Cash Volume ADXN|ALZN (Alzamend Neuro) - Company Cash on Hand|Company Cash and Cash Equivalents CYCN|PTIX (Protagenic Therapeutics, Inc.) - Company Cash Volume|KTTA: Company Cash Balance|Company Cash Funds Cortigent Medical (CRGT)|ATXI - Company Cash Reserve|Company Cash Volume BCLI (Brainstorm Cell Therapeutics Inc.)|Cara Therapeutics, Inc (CARA) - Company Cash Reserve|CHRO: Company Cash on Hand|ITCI - Company Cash Volume|Longboard Pharma (LBPH) - Company Cash Funds|Company Cash on Hand Marinus Pharmaceuticals|Company Cash Funds NKGen|Company Cash Volume NeuroBo Pharmaceuticals, Inc.|Company Cash Volume SAGE|Synaptogenix, Inc - Company Cash and Cash Equivalents|Company Cash Funds Trevena TRVN|Company Cash Position Vigil Neuroscience|Anew Medical Inc. - Company Cash Volume|Company Liquid Assets Cerevel Therapeutics, Inc. CERE